Bavarian Nordic A/S (BVNKF)
OTCMKTS
· Delayed Price · Currency is USD
24.23
0.00 (0.00%)
Mar 12, 2025, 4:00 PM EST
Bavarian Nordic Revenue
In the year 2024, Bavarian Nordic had annual revenue of 5.72B DKK, down -19.06%. Bavarian Nordic had revenue of 2.09B in the quarter ending December 31, 2024, a decrease of -14.44%.
Revenue
5.72B DKK
Revenue Growth
-19.06%
P/S Ratio
n/a
Revenue / Employee
3.56M DKK
Employees
1,605
Market Cap
1.85B USD
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.72B | -1.35B | -19.06% |
| Dec 31, 2023 | 7.06B | 3.91B | 124.14% |
| Dec 31, 2022 | 3.15B | 1.25B | 66.02% |
| Dec 31, 2021 | 1.90B | 45.49M | 2.46% |
| Dec 31, 2020 | 1.85B | 1.19B | 179.61% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.18B |
| SS Innovations International | 16.04M |
| Veradigm | 1.53B |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 188.29M |
| Northwest Biotherapeutics | 1.60M |
| Silence Therapeutics | 43.26M |
| BioStem Technologies | 210.49M |
Bavarian Nordic News
- 2 days ago - Bavarian Nordic A/S – Notice Convening Annual General Meeting - GlobeNewsWire
- 7 days ago - Bavarian Nordic Announces Acceptance of Marketing Authorization Application for Chikungunya Vaccine in the UK for Persons Aged 12 and Older - GlobeNewsWire
- 8 days ago - Bavarian Nordic A/S (BVNKF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such - GlobeNewsWire
- 9 days ago - Bavarian Nordic Publishes Annual Report 2024 - GlobeNewsWire
- 13 days ago - Bavarian Nordic Receives Marketing Authorization in Europe for Chikungunya Vaccine for Persons Aged 12 and Older - GlobeNewsWire
- 16 days ago - Biological E in strategic pact with Danish co Bavarian Nordic to manufacture Chikungunya vax for global access - The Times of India
- 17 days ago - Bavarian Nordic Partners with Biological E Limited to Expand Global Access to Chikungunya Vaccine - GlobeNewsWire